Retatrutide appears to be a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By boosting these https://siobhanbwka042848.tribunablog.com/retatrutide-a-promising-new-treatment-for-obesity-50615845